Full-Time

Group Leader

AI in Biology

Posted on 9/17/2025

Deadline 11/3/25
EMBL

EMBL

1,001-5,000 employees

Intergovernmental European life sciences research organization

Compensation Overview

€6.7k/mo

+ Salary

Bellheim, Germany

In Person

Category
Biology & Biotech (5)
, , , ,
Requirements
  • PhD in a relevant field
  • excellent research record in AI
  • interest in AI applications to biology
  • Previous experience in biology is not required, but a strong interest in interdisciplinary collaboration is essential
  • Scientific Excellence and Vision – you have the potential to develop groundbreaking ideas and contribute to shaping the future of their field
  • Original and Innovative Thinking – you are curious and intellectually creative to approach important research questions from new and original perspectives
  • Collaborative Mindset – you are eager to engage with a diverse community of researchers, willing to step outside of your comfort zone, and open to interdisciplinary exchange
  • Mentoring Skills – you are dedicated to nurturing and inspiring people in your team, supported by an inclusive leadership style
  • Leadership Potential and Management Skills – you are ready and committed to grow into a leadership role, including learning how to efficiently manage and inspire a research team, adapting strategic planning, coordination, and an environment that fosters inclusiveness.
Responsibilities
  • Lead an independent research group at EMBL AI’s Heidelberg Hub to pursue exciting, ambitious and original research in the broad domain of AI for biology
  • Create an innovative research program developing or adapting cutting-edge AI techniques to address important biological questions
  • Bring your perspective and unique vision to science in an intellectually stimulating, collaborative, interdisciplinary and highly international environment

EMBL is Europe’s flagship life sciences laboratory that conducts basic molecular biology research and runs a wide network of over 80 independent research groups across six sites (Heidelberg, Barcelona, Hamburg, Grenoble, Rome, and EMBL-EBI Hinxton). It also provides scientific services to member states, trains scientists and students, develops new instruments and methods for the life sciences, and engages in technology transfer to share discoveries. Its work is carried out by an intergovernmental organization dedicated to advancing European life science research. EMBL supports researchers through access to facilities and services, training programs, and collaborative projects, while coordinating and integrating resources across Europe and fostering tech transfer. Its goal is to advance fundamental science, enable scientific progress across Europe, and strengthen the ecosystem of life science research and innovation through collaboration, training, and shared tools.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Spain

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Boehringer Ingelheim Stiftung funds €7M in 2025, following €5M in 2017.
  • Supported over 290 projects from 27 countries since mid-2021.
  • Equipment donations from Zeiss, Leica, and Thermo Fisher equip latest microscopes.

What critics are saying

  • BIS withdraws after €12M total, collapsing services in 36-48 months.
  • Chan Zuckerberg Institute surpasses EMBL, diverting users in 12-24 months.
  • Euro-BioImaging nodes fragment user base to Barcelona in 6-18 months.

What makes EMBL unique

  • EMBL Imaging Centre pioneers open access to MINFLUX and cryo-electron tomography.
  • Partnership with Leica Microsystems provides on-site experts for sample-prep.
  • Plasma-FIB technology led by Julia Mahamid enables superior 3D FIB-SEM imaging.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Paid Vacation

Hybrid Work Options

Family Planning Benefits

401(k) Retirement Plan

Mental Health Support

Company News

Urban Innovation – Stadt neu denken! e.V.
Jul 23rd, 2025
Boehringer Ingelheim Stiftung funds EMBL €7M

Boehringer Ingelheim Stiftung has committed €7 million to support the EMBL Imaging Centre in Heidelberg, enhancing its development of cutting-edge imaging technologies. This is the second funding round from BIS, following an initial €5 million in 2017. The funding will help recruit and maintain highly qualified staff, furthering the centre's role as a leading international hub for advanced microscopy technologies and training, having supported over 290 projects from 27 countries since mid-2021.

INACTIVE